Circulating phenotypic B-1 cells are decreased in common variable immunodeficiency and correlate with immunoglobulin M levels

Clinical and Experimental Immunology

Volumn 171, Issue 3, 2013, Pages 278-282

  Kraljevic, K ^a   Wong, S ^b   Fulcher, D A ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Antibody deficiency; B cells; B 1 cells; B1 cells; Common variable immunodeficiency

Indexed keywords

IMMUNOGLOBULIN M;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOCYTE COUNT; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD27; B-LYMPHOCYTES; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED;

EID: 84873311358     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12008     Document Type: Article

References (18)

1. Baumgarth N. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat Rev Immunol 2011; 11:34-46.
2. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70- [Erratum appears in J Exp Med 2011 January 17;208(1):67]. J Exp Med 2011; 208:67-80.
3. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clinical Immunology 1999; 92:34-48.
4. Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000; 120:225-231.
5. Tangye SG, Liu YJ, Aversa G, Phillips JH, de Vries JE. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 1998; 188:1691-1703.
6. Baumgarth N, Herman OC, Jager GC, Brown L, Herzenberg LA. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci USA 1999; 96:2250-2255.
7. Mouillot G, Carmagnat M, Gerard L etal. B-cell and T-cell phenotypes in CVID patients correlate with the clinical phenotype of the disease. J Clin Immunol 2010; 30:746-755.
8. Piqueras B, Lavenu-Bombled C, Galicier L etal. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol 2003; 23:385-400.
9. Warnatz K, Denz A, Drager R etal. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99:1544-1551.
10. Wehr C, Kivioja T, Schmitt C etal. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 2008; 111:77-85.
11. Rakhmanov M, Gutenberger S, Keller B, Schlesier M, Peter H-H, Warnatz K. CD21low B cells in common variable immunodeficiency do not show defects in receptor editing, but resemble tissue-like memory B cells. Blood 2010; 116:3682-3683.
12. Livaditi O, Giamarellos-Bourboulis EJ, Kakkas I etal. Grouping of patients with common variable immunodeficiency based on immunoglobulin biosynthesis: comparison with a classification system on CD4-naive cells [Erratum appears in Immunol Lett 2008 April 15;117(1):121]. Immunol Lett 2007; 114:103-109.
13. Horn J, Manguiat A, Berglund LJ etal. Decrease in phenotypic regulatory T cells in subsets of patients with common variable immunodeficiency. Clin Exp Immunol 2009; 156:446-454.
14. Fulcher DA, Avery DT, Fewings NL etal. Invariant natural killer (iNK) T cell deficiency in patients with common variable immunodeficiency. Clin Exp Immunol 2009; 157:365-369.
15. Marron TU, Yu JE, Cunningham-Rundles C. Toll-like receptor function in primary B cell defects. Front Biosci (Elite edn) 2012; 4:1853-1863.
16. Yu JE, Knight AK, Radigan L etal. Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol 2009; 124:349-356, 56.e1-3.
17. Descatoire M, Weill J-C, Reynaud C-A, Weller S. A human equivalent of mouse B-1 cells? J Exp Med 2011; 208:2563-2564; author reply 6-9.
18. Perez-Andres M, Grosserichter-Wagener C, Teodosio C, van Dongen JJM, Orfao A, van Zelm MC. The nature of circulating CD27+CD43+ B cells. J Exp Med 2011; 208:2565-2566; author reply 6-9.